Creative Medical Technology
2007 W Peoria Avenue
Phoenix
Arizona
85029
United States
Tel: 602-680-7439
About Creative Medical Technology
Creative Medical Technology Holdings, Inc. (CMTH) is a clinical-stage biotechnology company focused on treating sexual dysfunction and infertility using stem cell treatments. Since 2011 Creative Medical Technology Holdings, Inc. (CMTH) and our affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for both male and female virility and fertility. Through our own research and collaborations with leading academic institutions, CMT has developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction and male infertility and are breaking new ground for new treatments in female sexual dysfunction and fertility. Our team consists of leading international researchers in regenerative medicine. Our “science-first” approach to treatments ensures that all of our treatments are proven to be both safe and effective.YEAR FOUNDED:
2011
LEADERSHIP:
CEO: Timothy Warbington
CFO: Donald Dickerson
CSO: Annette Marleau
58 articles about Creative Medical Technology
-
Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model
12/29/2020
Company Files Patent on Approaching 10 Billion Dollar Liver Disease Market Using Immune Cells
-
Creative Medical Technology Holdings Reports Positive Preclinical Data on ImmCelz® Immunotherapy Product in Rheumatoid Arthritis Model
9/29/2020
Creative Medical Technology Holdings announced today proof of concept studies demonstrating efficacy of its ImmCelz ® immunotherapy product in the collage induced model of rheumatoid arthritis.
-
Creative Medical Technology Holdings Completes AmnioStem™ Preclinical Studies Needed for FDA Investigational New Drug Application Filing
7/9/2020
Company Completes Critical Milestone in Development of "Universal Donor" Stem Cell Therapy for Stroke
-
Creative Medical Technology Holdings is Granted Patent on Mesenchymal Stem Cells for Female Infertility Pending Quayle Action
4/20/2020
Creative Medical Technology Holdings Inc. (OTC-CELZ) announced today receipt of a Quayle Action on its patent application #15/652213 entitled Methods for Treatment of Premature Ovarian Failure and Ovarian Aging using Regenerativ
-
Creative Medical Technology Holdings, Inc. February 2020 Shareholder Update
2/13/2020
PHOENIX , Feb. 13, 2020 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using adult stem cell treatments, today announced business updates and plans for 2020. Recent Business Highlights: CaverStem ® Regenerativ
-
StemSpine® to Launch in the United States Following Successful Treatments Overseas with 12+ Months Data Showing Safety and Efficacy
10/17/2019
Creative Medical Technology Holdings, Inc., a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, announced the successful clinical commercialization of StemSpine®.
-
October 2019 Shareholder Update: We Promised, We Delivered
10/10/2019
Creative Medical Technology Holdings, Inc., a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, provided shareholder updates.
-
100+ Patients Treated for Erectile Dysfunction Utilizing Company's Patented CaverStem® Stem Cell Procedure with Significant Success Rate and No Adverse Effects Reported
6/20/2019
Creative Medical Technology Holdings, Inc., a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using stem cell treatments, announced business updates and plans for remainder of 2019.
-
CaverStem Stem Cell Treatment Of Erectile Dysfunction Receives Additional International Exposure
5/6/2019
Creative Medical Technology Holdings, Inc. announced coverage of its patented CaverStem® technology for treatment of erectile dysfunction using the patient's own non-manipulated and non-expanded stem cells in multiple Italian publications.
-
Creative Medical Technology Holdings, Inc. April 2019 Shareholder Update
4/30/2019
Creative Medical Technology Holdings, Inc. announced today an update of its activities
-
Creative Medical Technology Holdings, Inc. March 28, 2019 Shareholder Update
3/28/2019
Creative Medical Technology Holdings, Inc. announced an update of its activities
-
Creative Medical Technology Holdings, Inc. December 2018 Shareholder Update
12/27/2018
Creative Medical Technology Holdings, Inc. announced today an update of its activities
-
Shareholder Update November 14, 2018: Creative Medical Technology Holdings, Inc.
11/14/2018
Creative Medical Technology Holdings, Inc. announced today an update of its activities
-
Shareholder Update September 24, 2018: Creative Medical Technology Holdings, Inc.
9/24/2018
Creative Medical Technology Holdings, Inc. announced today an update of its progress
-
Shareholder Update as of September 4, 2018: Creative Medical Technology Holdings, Inc.
9/4/2018
Creative Medical Technology Holdings, Inc. announced today an update of its activities.
-
Shareholder Update: Creative Medical Technology Holdings, Inc.
8/14/2018
Creative Medical Technology Holdings, Inc. announced today an update of its corporate activities.
-
Creative Medical Technology Holdings Announces Caverstem Contract For Russia
7/19/2018
Creative Medical Technology Holdings Inc. announced that its subsidiary Caverstem International LLC has signed an exclusive contract with Promo Med Russia for the commercialization of its CaverStemTM technology.
-
Creative Medical Technology Holdings Aims to Treat Cancer Associated Wasting (Cachexia) Using AmnioStem Universal Donor Stem Cell
7/6/2018
Company Sees Possible Access to AmnioStemTM for Cancer Patients under "Right to Try" Law
-
Shareholder Update: Award winning sales executive to join company as Vice President of Sales
5/30/2018
Creative Medical Technology Holdings, Inc. announced that Gary Mells has been hired to lead the CaverStem™ marketing and sales division of the company.
-
Shareholder Update: Creative Medical Technology Holdings, Inc. Continues To Extinguish Debt
4/30/2018
Creative Medical Technology Holdings, Inc. announced that debt to two lenders in the amount of $163,000.00 has been retired.